Aligos is a preclinical stage biotechnology company that researches and develops novel therapies for hepatologic diseases and viral infections.
Business Model:
Revenue: $10.7M
Employees: 51-200
Address: 1 Corporate Drive
City: San Francisco
State: CA
Zip: 94080
Country: US
Aligos is a preclinical stage biotechnology company that researches and develops novel therapies for hepatologic diseases and viral infections.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
10/15/2020
IPO Valuation:
$507M
Ticker Symbol:
ALGS
IPO Price:
$15/share
Amount Raised:
$150M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2020 | Series B | 10 | $125M |
Janus Henderson Investors Vivo Capital Novo Holdings Logos Capital Roche Venture Fund Pivotal bioVenture Partners Versant Ventures Boxer Capital Cormorant Asset Management Wellington Management Wellington Management Janus Henderson Investors Vivo Capital Novo Holdings Logos Capital Roche Venture Fund Pivotal bioVenture Partners Versant Ventures Boxer Capital Cormorant Asset Management Wellington Management Wellington Management |
7/2021 | Post-IPO Equity | $83.6M | 10/2020 | IPO | $150M |
|
11/2018 | Series A | $100M |
Vivo Capital Versant Ventures Novo Holdings |
1/2018 | Series A | 4 | $100M |
Vivo Capital Versant Ventures Roche Venture Fund Novo Holdings |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|